Cover Picture: Bisamidate Prodrugs of 2‐Substituted 9‐[2‐(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis (ChemMedChem 8/2015). Issue 8 (August 2015)
- Record Type:
- Journal Article
- Title:
- Cover Picture: Bisamidate Prodrugs of 2‐Substituted 9‐[2‐(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis (ChemMedChem 8/2015). Issue 8 (August 2015)
- Main Title:
- Cover Picture: Bisamidate Prodrugs of 2‐Substituted 9‐[2‐(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis (ChemMedChem 8/2015)
- Authors:
- Česnek, Michal
Jansa, Petr
Šmídková, Markéta
Mertlíková‐Kaiserová, Helena
Dračínský, Martin
Brust, Tarsis F.
Pávek, Petr
Trejtnar, František
Watts, Val J.
Janeba, Zlatko - Abstract:
- <abstract abstract-type="graphical" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>The front cover picture shows</bold> the molecular mechanism of inhibition of adenylate cyclase (AC) toxin (ACT) from <italic>Bordetella pertussis</italic>, the pathogen that causes whooping cough. Upon activation by endogenous calmodulin (CaM), ACT converts ATP into cAMP causing intracellular cAMP concentrations to increase to supraphysiologic levels in an unregulated manner and disruption of the host cell functions. Novel C‐2‐modified analogues of 9‐[2‐(phosphonomethoxy)ethyl]adenine (PMEA, adefovir) in the form of their bisamidate prodrugs were designed and found to be efficient ACT inhibitors. The compounds displayed favorable plasma stability, the ability to be effectively distributed to target tissues, as well as good selectivity for ACT over human AC isoforms AC1, AC2 and AC5. Thus, ACT inhibition with acyclic nucleoside phosphonates may represent a viable strategy to treat whooping cough. For further details, see the Full Paper by M. Šmídková, Z. Janeba, et al. on <ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">p. 1351 ff.</ext-link><graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgj23tcj48h" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></p> </abstract>
- Is Part Of:
- ChemMedChem. Volume 10:Issue 8(2015:Aug.)
- Journal:
- ChemMedChem
- Issue:
- Volume 10:Issue 8(2015:Aug.)
- Issue Display:
- Volume 10, Issue 8 (2015)
- Year:
- 2015
- Volume:
- 10
- Issue:
- 8
- Issue Sort Value:
- 2015-0010-0008-0000
- Page Start:
- 1277
- Page End:
- 1277
- Publication Date:
- 2015-08
- Subjects:
- Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201590023 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4345.xml